These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1280444)

  • 1. Therapeutic applications of oligonucleotides.
    Crooke ST
    Biotechnology (N Y); 1992 Aug; 10(8):882-6. PubMed ID: 1280444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward oligonucleotide therapeutics: pharmacodynamic properties.
    Crooke ST
    FASEB J; 1993 Apr; 7(6):533-9. PubMed ID: 7682523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of in vitro pre-mRNA splicing in S. cerevisiae by branched oligonucleotides.
    Carriero S; Braich RS; Hudson RH; Anglin D; Friesen JD; Damha MJ
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):873-7. PubMed ID: 11563135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic oligonucleotides.
    Goodchild J
    Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing unintended hybridization-induced biological effects of oligonucleotides.
    Lindow M; Vornlocher HP; Riley D; Kornbrust DJ; Burchard J; Whiteley LO; Kamens J; Thompson JD; Nochur S; Younis H; Bartz S; Parry J; Ferrari N; Henry SP; Levin AA
    Nat Biotechnol; 2012 Oct; 30(10):920-3. PubMed ID: 23051805
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of hybridization kinetics for differentiating specific from non-specific binding to oligonucleotide microarrays.
    Dai H; Meyer M; Stepaniants S; Ziman M; Stoughton R
    Nucleic Acids Res; 2002 Aug; 30(16):e86. PubMed ID: 12177314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying pre-mRNA splicing using antisense 2-OMe RNA oligonucleotides.
    Lamond AI; Barabino S; Blencowe BJ; Sproat B; Ryder U
    Mol Biol Rep; 1990; 14(2-3):201. PubMed ID: 1694562
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeutics.
    Menzi M; Lightfoot HL; Hall J
    Future Med Chem; 2015; 7(13):1733-49. PubMed ID: 26424049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights from crystallographic studies into the structural and pairing properties of nucleic acid analogs and chemically modified DNA and RNA oligonucleotides.
    Egli M; Pallan PS
    Annu Rev Biophys Biomol Struct; 2007; 36():281-305. PubMed ID: 17288535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual ligation hybridization assay for the specific determination of oligonucleotide therapeutics.
    Tremblay G; Khalafaghian G; Legault J; Nielsen P; Bartlett A
    Bioanalysis; 2011 Mar; 3(5):499-508. PubMed ID: 21388263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted random mutagenesis: the use of ambiguously synthesized oligonucleotides to mutagenize sequences immediately 5' of an ATG initiation codon.
    Matteucci MD; Heyneker HL
    Nucleic Acids Res; 1983 May; 11(10):3113-21. PubMed ID: 6304623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines and therapeutic oligonucleotides.
    Hartmann G; Bidlingmaier M; Eigler A; Hacker U; Endres S
    Cytokines Cell Mol Ther; 1997 Dec; 3(4):247-56. PubMed ID: 9740353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligonucleotide therapeutics: chemistry, delivery and clinical progress.
    Sharma VK; Watts JK
    Future Med Chem; 2015; 7(16):2221-42. PubMed ID: 26510815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
    Orum H; Wengel J
    Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking.
    Mangla P; Vicentini Q; Biscans A
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA.
    Bruice TW; Lima WF
    Biochemistry; 1997 Apr; 36(16):5004-19. PubMed ID: 9125523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating Disease at the RNA Level with Oligonucleotides.
    Levin AA
    N Engl J Med; 2019 Jan; 380(1):57-70. PubMed ID: 30601736
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding of short oligonucleotides to RNA: studies of the binding of common RNA structural motifs to isoenergetic microarrays.
    Kierzek E
    Biochemistry; 2009 Dec; 48(48):11344-56. PubMed ID: 19835418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide delivery: a patent review (2010 - 2013).
    Grijalvo S; Aviñó A; Eritja R
    Expert Opin Ther Pat; 2014 Jul; 24(7):801-19. PubMed ID: 24798406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.